059 A phase 3, randomised controlled trial comparing upadacitinib monotherapy to MTX monotherapy in MTX-naïve patients with active rheumatoid arthritis. (12th April 2019) - van Vollenhoven, R; Takeuchi, T; Pangan, A L; Friedman, A; Mohamed, M F; Chen, S; Rischmueller, M; Blanco, R; Xavier, R M; Strand, V